Gameto
Gameto is a clinical-stage biotechnology company focused on developing innovative stem cell-derived therapies to address reproductive health challenges. The company is actively advancing its research to provide cutting-edge solutions in the biopharma sector, aiming to enhance fertility treatments and improve access to reproductive healthcare.
Leadership & Board
- Current Number of Employees
- 59
- Current LinkedIn Followers
- 22,090
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $44M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $44M
- Latest Funding Round
- Series C
- Post-Money Valuation
- ―
Company Momentum Positive
Gameto LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Gameto had 59 employees as of October 12, 2026. The number of employees increased by 1 (1.72%) week-over-week.
Social Trend
Gameto had 22,090 followers as of October 12, 2026. The number of followers increased by 42 (0.19%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series C | $44.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Overwater Ventures | Series C |
| Insight Partners | Series C |
| RA Capital | Series C |
| Two Sigma Ventures | Series C |
| BOLD Capital Partners | Series C |
| Future Ventures | Series C |
| Ingeborg Investments | Series C |
| Arcadia Investment Partners | Series C |
Similar Companies
A snapshot of private companies similar to Gameto, helping you discover and navigate related company profiles.
Related News and Analysis
